Bazil Azmil

Bazil Azmil is the VP of Business Development at Mymee, a company that specializes in personalized trials and care for individuals with autoimmune rheumatic conditions and long COVID symptoms.13 He is based in Berlin, Germany, and brings valuable experience from his previous roles in the digital health sector.3

Prior to joining Mymee, Bazil Azmil was associated with Breakthrough Health, a company that was acquired by Mymee in July 2022.2 This acquisition highlights his involvement in the growth and expansion of Mymee's capabilities in the precision care and nutrition space.

Bazil Azmil is passionate about the role of technology in advancing health, science, and research.6 His professional interests are focused on digital health, particularly in areas related to autoimmune conditions and personalized care. He has been actively involved in various initiatives and programs within the healthcare startup ecosystem, as evidenced by his announcement of Breakthrough Health winning the MS challenge from EIT Health's Startups Meet Pharma program in October 2021.4

As part of the Mymee management team, Bazil Azmil works alongside other key executives such as Mette Dyhrberg (Founder & CEO) and Stefano Palazzo (Chief Technology Officer).5 His role as VP of Business Development likely involves driving strategic partnerships, identifying growth opportunities, and expanding Mymee's presence in the digital health market.